Skip to content

13F-HR filed by RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:31:36 UTC, with 92 holding rows worth $9,969,410,191.

Accession
0001104659-26-128411
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 92 entries on the cover page, a total value of $9,969,410,191 stated on the cover page (in dollars after the unit check, H1), rows summing to $9,969,410,191 with VALUE read as dollars as filed, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ASCENDIS PHARMA A/SK08588103ORD SHS *A*10,281,496$2,342,433,234dollars as filed
PARABILIS MEDICINES INC COM698955101Stock29,177,964$942,156,458dollars as filed
VAXCYTE INC COM92243G108Stock11,474,599$652,904,683dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM6,666,837$634,782,885dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM8,392,730$340,744,838dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK12,198,625$266,783,929dollars as filed
FREENOME INC35661P100COMMON STOCK15,367,270$242,034,503dollars as filed
HEMAB THERAPEUTICS HLDGS INC423494103COM SHS7,808,627$240,818,057dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK9,550,191$232,260,645dollars as filed
SEPTERNA INC COM81734D104Stock5,502,858$215,326,834dollars as filed
SPYGLASS PHARMA INC85220G109COMMON STOCK8,021,117$208,549,042dollars as filed
JANUX THERAPEUTICS INC47103J105COM11,189,693$193,357,895dollars as filed
MINERALYS THERAPEUTICS INC603170101COM7,692,750$193,318,808dollars as filed
DISC MEDICINE INC COM254604101Stock2,450,221$160,391,467dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK30,435,190$148,219,375dollars as filed
BICARA THERAPEUTICS INC055477103COM7,255,993$135,034,030dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM18,489,293$131,643,766dollars as filed
XENCOR INC98401F105COMMON STOCK5,274,274$131,593,136dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock1,554,597$129,482,384dollars as filed
AMYLYX PHARMACEUTICALS INC03237H101COM4,279,341$124,528,823dollars as filed
CLIMB BIO INC28658R106COMMON STOCK10,130,130$116,192,591dollars as filed
ABIVAX SA-00370M103SPONSORED ADS1,030,058$101,996,343dollars as filed
Wave Life Sciences Inc.94352A104COM26,975,505$99,809,369dollars as filed
Latigo Biotherapeutics, Inc.517954103Common Stock, par value $0.0001 per share5,302,933$88,558,981dollars as filed
SOLID BIOSCIENCES INC83422E204COMMON STOCK12,036,126$87,021,191dollars as filed
VOR BIOPHARMA INC929033207COMMON STOCK4,503,882$85,934,069dollars as filed
LB PHARMACEUTICALS INC50180M108COMMON STOCK2,208,604$84,766,222dollars as filed
GH RESEARCH PLC ORDINARY SHARESG3855L106Stock3,609,007$84,739,484dollars as filed
Obsidian Therapeutics, Inc.67448A106Common Stock, $0.0001 par value per share5,957,103$81,791,024dollars as filed
ZAI LAB LTD ADR98887Q104ADR2,815,543$74,161,403dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock5,049,779$72,262,337dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock12,723,026$66,923,117dollars as filed
SANA BIOTECHNOLOGY INC799566104COM18,750,000$54,656,250dollars as filed
MONOPAR THERAPEUTICS INC61023L207COMMON STOCK667,207$53,156,382dollars as filed
GERON CORP374163103COM42,754,145$52,587,598dollars as filed
DAMORA THERAPEUTICS INCG2646Y104COMM STK2,399,702$51,065,659dollars as filed
PEPGEN INC COM713317105Stock20,064,545$48,556,199dollars as filed
ARS PHARMACEUTICALS INC82835W108COM10,860,977$46,810,811dollars as filed
ACUMEN PHARMACEUTICALS INC00509G209CMN20,992,669$46,603,725dollars as filed
DBV TECHNOLOGIES S A23306J309SPONSORED ADS3,657,644$43,013,893dollars as filed
AGENUS INC00847G804COM NEW4,122,000$40,931,460dollars as filed
REZOLUTE INC76200L309COMMON STOCK9,445,039$39,102,461dollars as filed
SIONNA THERAPEUTICS INC829401108COMMON STOCK6,456,234$33,959,791dollars as filed
SCRIBE THERAPEUTIC COM811033109COM1,802,178$33,169,086dollars as filed
CENTURY THERAPEUTICS INC15673T100COM17,754,430$30,360,075dollars as filed
EVOMMUNE INC30054Y107COMMON STOCK3,494,638$28,865,710dollars as filed
KORSANA BIOSCIENCES INC23255M303COMMON STOCK892,743$28,567,776dollars as filed
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK3,014,183$28,544,313dollars as filed
NKARTA INC65487U108COMMON STOCK10,805,129$28,309,438dollars as filed
C4 THERAPEUTICS INC12529R107COM STK8,194,779$27,288,614dollars as filed
JADE BIOSCIENCES INC008064206COM NEW1,835,542$25,789,365dollars as filed
PRELUDE THERAPEUTICS INC74065P101CMN6,475,882$25,320,699dollars as filed
ACRIVON THERAPEUTICS INC004890109CMN12,229,396$25,070,262dollars as filed
ASSEMBLY BIOSCIENCES INC045396207COMMON STOCK1,020,410$23,969,431dollars as filed
EDITAS MEDICINE INC28106W103COM8,889,000$22,844,730dollars as filed
Q32 BIO INC746964105Common Stock2,332,457$19,289,419dollars as filed
ANTERIS TECHNOLOGIES GLOBAL03675P102COMMON STOCK2,474,076$19,223,571dollars as filed
Electra Therapeutics, Inc.284825106Common Stock, $0.0001 par value per share1,692,965$19,045,856dollars as filed
ALTIMMUNE INC02155H200COM NEW6,500,000$18,590,000dollars as filed
BENITEC BIOPHARMA INC08205P209COMMON STOCK1,850,000$18,500,000dollars as filed
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK13,011,849$18,086,470dollars as filed
SAGIMET BIOSCIENCES INC A786700104COMMON STOCK1,800,000$17,784,000dollars as filed
LEXEO THERAPEUTICS INC52886X107COMMON STOCK5,000,000$16,900,000dollars as filed
LENZ THERAPEUTICS INC52635N103COM4,178,823$16,046,680dollars as filed
AURA BIOSCIENCES INC05153U107COMMON STOCK2,500,000$15,700,000dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK1,000,000$15,330,000dollars as filed
INHIBIKASE THERAPEUTICS INC45719W205COMMON STOCK6,970,000$14,323,350dollars as filed
ENTERA BIO LTDM40527109SHS4,901,960$14,264,704dollars as filed
SEAPORT THERAPEUTICS INC81221K108COMMON STOCK700,000$14,119,000dollars as filed
SAB BIOTHERAPEUTICS INC78397T202COMMON STOCK4,401,500$13,952,755dollars as filed
OVID THERAPEUTICS INC690469101COMMON STOCK5,598,200$13,939,518dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM159,278$13,615,083dollars as filed
HELIX ACQUISITION CORP IIIG4444S107USD CL A ORD SHS1,250,000$13,275,000dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK265,000$13,202,300dollars as filed
CORBUS PHARMACEUTICALS21833P301COM NEW1,914,788$13,058,854dollars as filed
Braveheart Bio Inc10567X101COM565,000$11,413,000dollars as filed
ONKURE THERAPEUTICS INC68277Q105COM CL A3,998,333$10,895,457dollars as filed
PALISADE BIO INC696389402COMMON STOCK7,124,116$9,617,557dollars as filed
INOVIO PHARMACEUTICALS I45773H409COMMON STOCK7,220,384$8,808,868dollars as filed
MACROGENICS INC556099109COM1,864,176$7,195,719dollars as filed
RANI THERAPEUTICS HLDGS INC753018100CMN8,500,000$6,723,500dollars as filed
ADICET BIO INC007002207COM NEW932,624$6,658,935dollars as filed
TCGX ACQUISITION CORPG8708J109COM500,000$6,255,000dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW205,060$6,098,484dollars as filed
JATT II ACQUISITION CORPG50765109ORD SHS500,000$5,622,500dollars as filed
JATT III ACQUISITION CORPG5080G109COM450,000$4,959,000dollars as filed
NEWAMSTERDAM PHARMA CO NV-27N62509117WTS333,333$4,216,662dollars as filed
AMANAT ACQUISITION CORPG0375M101CL A ORD375,000$4,005,000dollars as filed
EQUILLIUM INC29446K106COM2,317,741$3,766,329dollars as filed
SUTRO BIOPHARMA INC869367201COMMON STOCK210,934$3,398,147dollars as filed
STOKE THERAPEUTICS INC86150R107COM73,607$1,913,782dollars as filed
PALATIN TECHNOLOGIES INC696077601COM NEW62,124$551,040dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-26-128411this filing2026-11-16